A University of Bristol study finds trained detection dogs can identify Parkinson's disease with up to 98% accuracy by smelling skin swabs, offering promise for early, non-invasive diagnosis.
A new global study reveals that people diagnosed with dementia are living longer than before, thanks to earlier diagnosis and advancements in care that reduce the risk of death post-diagnosis.
A WHO report reveals that social connection improves health and lowers the risk of early death, with one in six people experiencing loneliness globally.
Cardiff University spin-out Draig Therapeutics has been awarded £107m ($140m) to advance the development of novel therapies for major neuropsychiatric disorders.
There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
